# Study on Recurrence Monitoring of Hepatocellular Carcinoma With 5-Hydroxymethylcytosine Test

> **NCT03493763** · — · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** 5hmC profile in plasma cell-free DNA after liver resection

## Key facts

- **NCT ID:** NCT03493763
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-03-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2018-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03493763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03493763, "Study on Recurrence Monitoring of Hepatocellular Carcinoma With 5-Hydroxymethylcytosine Test". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03493763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*